From advanced wound care through surgery and sports medicine, we are committed to empowering healing by confidently and reliably delivering clinicians the range of regenerative tissue innovations along with the services they need.
Designed for the management of chronic and acute wounds, our portfolio of advanced wound care solutions can support patients from early in the wound healing process through to wound closure—regardless of wound type.

Founded in 2019 and headquartered in Carlisle, PA, Advanced Solution LLC leads the way in regenerative medicine and wound care distribution. Committed to innovation and excellence, the company empowers healthcare providers with turnkey solutions that optimize patient outcomes while maximizing revenue generation. Its flagship programs that offer premium biological products supported by prompt delivery, personalized implementation, and comprehensive clinical tools. Through its proprietary Tissue Vault™ software and FDA-registered Tissue Banks, Advanced Solution streamlines benefit verification, ordering, and logistics, setting the standard for efficiency and reliability. With an unwavering focus on compliance, innovation, and compassion, the company has achieved significant milestones, including the development of cutting-edge logistics infrastructure and the publication of Got Wounds? Wound Care Essentials 101, a cornerstone resource for advanced wound care techniques. Whether serving private practices, government facilities, or hospital systems, Advanced Solution remains a trusted partner dedicated to transforming healthcare delivery. By integrating advanced technologies and expert-driven strategies, Advanced Solution ensures exceptional outcomes for providers and patients alike.

BioLab Holdings is a biotechnology company committed to raising the standard of caring by developing, manufacturing, and commercializing breakthrough products with patient care in mind. At the heart of our work is a mission to optimize the standard of wound care through innovations grounded in science, compassion, and collaboration. We support healthcare distributors, providers, and patients worldwide who share our same initiatives to deliver clinical performance and real-world impact.

Tiger Wound Care is a “first of its kind“ wound care distribution company committed to advancing wound care through innovative and science-driven products.
Tiger Wound Care is a vertically-integrated business, which allows us effectively to bridge the gap between scientific research and real-world medical applications to support clinicians and patients with cutting-edge wound care technologies.
By integrating tissue research, development, clinical expertise, processing, and nationwide distribution under one organization, Tiger Wound Care is successfully able to deliver safe and effective tissue-based products to healthcare providers and patients

Established in 2009, Venture Medical has pioneered novel solutions in wound care including biofilm management, imaging, diagnostics, and biologic allografts, while expanding access to therapies in multiple care environments. Since its beginning as a small group in the Northwest, Venture Medical has grown to manage sales representation across the US, expanded research in
real world settings, and initiated new business models that enable innovative manufacturers to focus on product development and improvements. Interdisciplinary wound care organisation in the US, focused on education, public policy and the application of evidence-based wound care practice. Conceived in 1995, the mission of the AAWC is to advance the care of people with and at risk of wounds

New Horizon Medical Solutions' dedication to patient care sets us apart and drives us to bring high-quality and effective products to healthcare practices across the nation. We are a leading medical device company specializing in biologics and durable medical equipment (DME). Our network includes a diverse range of medical fi elds, such as orthopedic surgery, podiatry, wound care, dermatology, spine, and neurosurgery. Known for our commitment to innovation and excellence, New Horizon Medical Solutions strives to provide top-tier medical products that enhance patient care and improve outcomes

Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. Alongside
our customers we will not settle until we have solved the challenges of preventing and healing wounds, because they hold back too many lives.

Imbed Biosciences is a privately held medical device company and innovator of SAM™ Antimicrobial Technology, with both commercially available and emerging solutions for the treatment of chronic and acute wounds. Imbed’s revolutionary platform technology enhances skin regeneration by integrating multiple agents into an ultra-thin, biocompatible matrix to facilitate wound healing.

ProMed Billing Solutions recognizes the importance of prompt and accurate billing services. We are committed to providing our clients with services that are quicker and more effective than their current processes. Our dedicated staff has over 20 years of iindustry knowledge, experience, and are savvy in WoundCare billing and collections

Reprise Biomedical is focused on the development and commercialization of biological medical devices that offer advanced solutions for wound healing. In 2019, Reprise took ownership of two products, under a proprietary perfusion decellularization technology license from the University of Minnesota, MiroDerm biologic wound matrix for advanced wound management and MiroFlex biologic matrix for soft tissue reinforcement. Reprise is committed to delivering novel solutions which address unmet surgical needs for advanced wound care. Our transformational, Miro3D wound matrix, is an example of that commitment. Miro3D broadens our wound management portfolio by offering a unique three-dimensional solution for deep and tunnelling wounds

Kent Imaging, a leading innovator in tissue oxygenation assessment, designs and manufactures imaging technology that supports realtime decision-making in wound care, vascular and surgical specialties. Unlike some devices that only measure the macrovasculature, SnapshotNIR utilizes near-infrared light to go below the surface and measure tissue oxygen saturation, oxyhemoglobin, deoxyhemoglobin and total hemoglobin in the microvascular network. Use actionable data to document medical necessity, expedite vascular assessment, design treatment plans, and track and document therapeutic efficacy.

Convatec has the first and only FDA-cleared placental medical devices for chronic wounds, surgical wounds, and burns with its innovative InnovaMatrix® technology platform - now available in powder form and a variety of membrane sizes. For more information, visit www.innovamatrix.com.

AROA is based in Auckland, New Zealand, and has US distribution, sales, and customer services. The company is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. AROA is at the forefront of understanding how biology, structural form, and human factors affect healing and is applying its AROA ECM™ platform technology to unlock regenerative healing for everybody.

The MolecuLight i:X® and DX™ point-of-care imaging devices enable detection of elevated bacterial loads and accurate digital wound measurement. They facilitate proactive wound care and inform clinician decision-making in real-time including enabling guided cleaning and debridement. US reimbursement pathway is enabled, along with 80+ peer-reviewed publications.

At Cellution Biologics, we are a trusted partner in advanced human tissue-based products, driven by a commitment to innovation and a legacy of excellence in placental tissue banking. Leveraging our extensive expertise in tissue processing, we deliver transformative solutions that foster a healthier future.

ETS, headquartered in Rolla, Missouri, USA, specializes in developing medical products utilizing proprietary borate-based bioactive glass. Our fl agship product, Mirragen®, represents a breakthrough in wound care technology as the fi rst FDA-cleared inorganic bioactive glass-based solution. Mirragen® is a borate-based bioactive glass fi ber matrix that facilitates quality tissue formation, without the risk of infection that tissue-based products have, all in an easy to use, versatile form factor.